21h
Stocktwits on MSNMerck Enters $2B License Agreement With China-Based Hengrui Pharma For Heart Disease Drug: Retail’s UnswayedMerck & Co., Inc. (MRK) said on Tuesday that it hasentered into an exclusive license agreement with China-based Jiangsu ...
MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral small molecule Lp(a) inhibitor, HRS-5346.
For many consumers, employees and investors, trust isn't just a preference, it's a necessity. It shapes where people shop, ...
For the fourth time, Newsweek, in collaboration with market research partner Statista, recognizes the Most Trustworthy Companies in America across 23 industries, based on evaluations of U.S. residents ...
The Global 3D Cell Culture Market is expected to witness a double-digit growth rate by 2027. Some of the key factors driving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results